U.S. regulators launch new review of infant RSV therapies from Merck, Sanofi, and AstraZeneca amid scrutiny by Health Secretary Robert F. Kennedy Jr.

HealthDay News — Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems have been reported. The review covers Beyfortus (from Sanofi ...

GSK said on Friday a panel of the European Medicines Agency had backed the use of its respiratory syncytial virus (RSV) ...

Covid vaccines slashed emergency room visits among children last year, a real-world analysis from the US Centers for Disease ...

An internal memo written by the Food and Drug Administration’s top vaccine regulator offers a concerning glimpse into the ...

FDA widens its Covid vaccine safety review as HHS Secretary Robert F. Kennedy Jr. questions longstanding guidance and companies defend their records.

The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective ...

The US Food and Drug Administration is taking a closer look at RSV shots for infants as Health and Human Services Secretary Robert F. Kennedy Jr. continues to push for changes to the country’s ...

As an FDA official said that the agency has evidence that links COVID vaccines to the deaths of at least 10 children, the U.S ...

An internal memo written by the Food and Drug Administration’s top vaccine regulator offers a concerning glimpse into the future of vaccine regulation in the US — and could have profound implications ...